Longevity Acquisition Corporation
Status: Closed Deal
U=S+W+R
W=S/2@11.5
R=S/10
| IPO Proceeds, $M | $40.00M |
|---|---|
| IPO Date | Aug 29, 2018 |
| CEO | Matthew Chen |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 12+3+3+3+6+6 |
| IPO Sector | General ▶ |
| IPO Geography | Asia |
| Target Company | 4D Pharma |
| Deal Announced | Oct 22, 2020 |
| Deal Size, $M | $184.40M |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Mar 17, 2021 |
| Amendment Vote | TBD |
| Closing Date | Mar 19, 2021 |
Formerly LOAC
LBPS
LBPSW
| Price | $0.00 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.